Ignite Creation Date:
2024-05-06 @ 6:40 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05741957
Status:
RECRUITING
Last Update Posted:
2023-05-11
First Post:
2023-02-13
Brief Title:
Optimal Exercise Frequency to Reduce Liver Fat in Centrally Obese Adults With Non-Alcoholic Fatty Liver Disease
Sponsor:
The University of Hong Kong
Organization:
The University of Hong Kong
Study Overview
Official Title:
Examining the Optimal Exercise Frequency for Alleviating Liver Fat in Centrally Obese Adults With Non-Alcoholic Fatty Liver Disease NAFLD A Comparative Randomized Controlled Trial
Status:
RECRUITING
Status Verified Date:
2023-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to examine the comparative effectiveness of different exercise frequencies once-a-week vs thrice-a-week for reducing liver fat in centrally obese adults with non-alcoholic fatty liver disease NAFLD with weekly exercise volumes aligned with the World Health Organizations physical activity recommendations
Detailed Description:
This study is a three-arm randomized controlled trial Participants will be randomly allocated to the once-a-week exercise group thrice-a-week exercise group or usual care control group The exercise intervention groups will receive once-a-week or thrice-a-week exercise with matched weekly exercise volumes The usual care control group will receive general health education All interventions will last for 4 months Outcome measures will be examined at baseline 4 months post-intervention and 10 months 6-month follow-up
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None